Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis-A Phase I Study.

Iacobaeus E, Kadri N, Lefsihane K, Boberg E, Gavin C, Törnqvist Andrén A, Lilja A, Brundin L, Blanc KL.

J Clin Med. 2019 Dec 2;8(12). pii: E2102. doi: 10.3390/jcm8122102.

2.

Mental fatigue after allogeneic hematopoietic stem cell transplantation is associated with cognitive dysfunction, but not central nervous system inflammation.

Boberg E, Kadri N, Winterling J, Davies LC, Björklund A, Msghina M, Iacobaeus E, Le Blanc K.

Haematologica. 2019 Oct 24. pii: haematol.2019.225326. doi: 10.3324/haematol.2019.225326. [Epub ahead of print]

3.

The Complement System Is Essential for the Phagocytosis of Mesenchymal Stromal Cells by Monocytes.

Gavin C, Meinke S, Heldring N, Heck KA, Achour A, Iacobaeus E, Höglund P, Le Blanc K, Kadri N.

Front Immunol. 2019 Sep 20;10:2249. doi: 10.3389/fimmu.2019.02249. eCollection 2019.

4.

Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis.

Iacobaeus E, Douagi I, Jitschin R, Marcusson-Ståhl M, Andrén AT, Gavin C, Lefsihane K, Davies LC, Mougiakakos D, Kadri N, Le Blanc K.

Immunol Cell Biol. 2018 Sep;96(8):820-830. doi: 10.1111/imcb.12042. Epub 2018 Apr 19.

PMID:
29569304
5.

The national incidence of PML in Sweden, 1988-2013.

Iacobaeus E, Burkill S, Bahmanyar S, Hakim R, Byström C, Fored M, Olsson T, Brundin L, Montgomery S.

Neurology. 2018 Feb 6;90(6):e498-e506. doi: 10.1212/WNL.0000000000004926. Epub 2018 Jan 10.

6.

Dynamic Changes in Brain Mesenchymal Perivascular Cells Associate with Multiple Sclerosis Disease Duration, Active Inflammation, and Demyelination.

Iacobaeus E, Sugars RV, Törnqvist Andrén A, Alm JJ, Qian H, Frantzen J, Newcombe J, Alkass K, Druid H, Bottai M, Röyttä M, Le Blanc K.

Stem Cells Transl Med. 2017 Oct;6(10):1840-1851. doi: 10.1002/sctm.17-0028. Epub 2017 Sep 23.

7.

Consensus guidelines for lumbar puncture in patients with neurological diseases.

Engelborghs S, Niemantsverdriet E, Struyfs H, Blennow K, Brouns R, Comabella M, Dujmovic I, van der Flier W, Frölich L, Galimberti D, Gnanapavan S, Hemmer B, Hoff E, Hort J, Iacobaeus E, Ingelsson M, Jan de Jong F, Jonsson M, Khalil M, Kuhle J, Lleó A, de Mendonça A, Molinuevo JL, Nagels G, Paquet C, Parnetti L, Roks G, Rosa-Neto P, Scheltens P, Skårsgard C, Stomrud E, Tumani H, Visser PJ, Wallin A, Winblad B, Zetterberg H, Duits F, Teunissen CE.

Alzheimers Dement (Amst). 2017 May 18;8:111-126. doi: 10.1016/j.dadm.2017.04.007. eCollection 2017.

8.

Brain endothelial cell expression of SPARCL-1 is specific to chronic multiple sclerosis lesions and is regulated by inflammatory mediators in vitro.

Bridel C, Koel-Simmelink MJA, Peferoen L, Derada Troletti C, Durieux S, Gorter R, Nutma E, Gami P, Iacobaeus E, Brundin L, Kuhle J, Vrenken H, Killestein J, Piersma SR, Pham TV, De Vries HE, Amor S, Jimenez CR, Teunissen CE.

Neuropathol Appl Neurobiol. 2018 Jun;44(4):404-416. doi: 10.1111/nan.12412. Epub 2017 Jun 28.

PMID:
28543098
9.

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.

Burman J, Iacobaeus E, Svenningsson A, Lycke J, Gunnarsson M, Nilsson P, Vrethem M, Fredrikson S, Martin C, Sandstedt A, Uggla B, Lenhoff S, Johansson JE, Isaksson C, Hägglund H, Carlson K, Fagius J.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1116-21. doi: 10.1136/jnnp-2013-307207. Epub 2014 Feb 19.

PMID:
24554104
10.

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis.

Teunissen C, Menge T, Altintas A, Álvarez-Cermeño JC, Bertolotto A, Berven FS, Brundin L, Comabella M, Degn M, Deisenhammer F, Fazekas F, Franciotta D, Frederiksen JL, Galimberti D, Gnanapavan S, Hegen H, Hemmer B, Hintzen R, Hughes S, Iacobaeus E, Kroksveen AC, Kuhle J, Richert J, Tumani H, Villar LM, Drulovic J, Dujmovic I, Khalil M, Bartos A.

Mult Scler. 2013 Nov;19(13):1802-9. doi: 10.1177/1352458513488232. Epub 2013 May 21.

PMID:
23695446
11.

Analysis of JC virus DNA in NPSLE patients treated with different immunomodulatory agents.

Iacobaeus E, Hopia L, Khademi M, Lundén M, Hammarin AL, Svenungsson E, Andersson M.

Lupus. 2013 Mar;22(3):307-11. doi: 10.1177/0961203312470977. Epub 2012 Dec 20.

PMID:
23257400
12.

Progressive multifocal leukoencephalopathy in a patient with polymyositis: case report and literature review.

Dastmalchi M, Laki J, Lundberg IE, Iacobaeus E.

J Rheumatol. 2012 Jun;39(6):1299-303. doi: 10.3899/jrheum.111126. Review. No abstract available.

PMID:
22661423
13.

The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosis.

Iacobaeus E, Amoudruz P, Ström M, Khademi M, Brundin L, Hillert J, Kockum I, Malmström V, Olsson T, Tham E, Piehl F.

PLoS One. 2011 May 6;6(5):e19138. doi: 10.1371/journal.pone.0019138.

14.

Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.

Khademi M, Kockum I, Andersson ML, Iacobaeus E, Brundin L, Sellebjerg F, Hillert J, Piehl F, Olsson T.

Mult Scler. 2011 Mar;17(3):335-43. doi: 10.1177/1352458510389102. Epub 2010 Dec 6.

PMID:
21135023
15.

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.

Teunissen CE, Iacobaeus E, Khademi M, Brundin L, Norgren N, Koel-Simmelink MJ, Schepens M, Bouwman F, Twaalfhoven HA, Blom HJ, Jakobs C, Dijkstra CD.

Neurology. 2009 Apr 14;72(15):1322-9. doi: 10.1212/WNL.0b013e3181a0fe3f.

PMID:
19365053
16.

Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.

Vogt MH, Teunissen CE, Iacobaeus E, Heijnen DA, Breij EC, Olsson T, Brundin L, Killestein J, Dijkstra CD.

J Neurol Neurosurg Psychiatry. 2009 Oct;80(10):1110-5. doi: 10.1136/jnnp.2008.146357. Epub 2008 Oct 17.

PMID:
18931010
17.

Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.

Iacobaeus E, Ryschkewitsch C, Gravell M, Khademi M, Wallstrom E, Olsson T, Brundin L, Major E.

Mult Scler. 2009 Jan;15(1):28-35. doi: 10.1177/1352458508096870. Epub 2008 Sep 19.

18.

Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis.

Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallström E, Khademi M, Oturai A, Ryder LP, Saarela J, Harbo HF, Celius EG, Salter H, Olsson T, Hillert J.

Nat Genet. 2007 Sep;39(9):1108-13. Epub 2007 Jul 29.

PMID:
17660816
19.

Eae19, a new locus on rat chromosome 15 regulating experimental autoimmune encephalomyelitis.

Sheng JR, Jagodic M, Dahlman I, Becanovic K, Nohra R, Marta M, Iacobaeus E, Olsson T, Wallström E.

Genetics. 2005 May;170(1):283-9. Epub 2005 Feb 16.

20.

Curative effects of recombinant human Interleukin-6 in DA rats with protracted relapsing experimental allergic encephalomyelitis.

Di Marco R, Khademi M, Wallstrom E, Iacobaeus E, Salvaggio A, Caracappa S, Papoian R, Nicoletti F, Olsson T.

J Neuroimmunol. 2001 Jun 1;116(2):168-77.

PMID:
11438171

Supplemental Content

Loading ...
Support Center